Covered recipient · General Payments record
WHITNEY MESSER ABEL
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2022–2025
$1,807.63
- Reported across 21 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $775.92 | 9 |
| Education | $153.98 | 2 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Daiichi Sankyo Inc. | $265.75 | 3 |
| Acerta Pharma LLC | $139.58 | 1 |
| Exelixis Inc. | $125.01 | 1 |
| Ipsen Biopharmaceuticals, Inc | $114.24 | 2 |
| E.R. Squibb & Sons, L.L.C. | $108.49 | 1 |
| Astellas Pharma US Inc | $95.30 | 2 |
| ABBVIE INC. | $81.53 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $81.53 | 10/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204876269 | CMS |
| Astellas Pharma US Inc | $31.31 | 06/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238802813 | CMS |
| Astellas Pharma US Inc | $63.99 | 08/11/2025 | Education | Undisputed | 06/30/2026 | 1238612340 | CMS |
| AstraZeneca Pharmaceuticals LP | $139.58 | 10/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206299580 | CMS |
| Daiichi Sankyo Inc. | $121.35 | 03/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1197054483 | CMS |
| Daiichi Sankyo Inc. | $120.87 | 09/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1197025533 | CMS |
| Daiichi Sankyo Inc. | $23.53 | 10/31/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1197005551 | CMS |
| E.R. Squibb & Sons, L.L.C. | $108.49 | 10/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1223255474 | CMS |
| Exelixis Inc. | $125.01 | 09/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1218825512 | CMS |
| Ipsen Biopharmaceuticals, Inc | $89.99 | 12/09/2025 | Education | Undisputed | 06/30/2026 | 1208854405 | CMS |
| Ipsen Biopharmaceuticals, Inc | $24.25 | 12/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1208854407 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.